- SPANNR
- Posts
- Issue #31
Issue #31
Issue #31
December 22, 2022 | Issue #31
Good Evening
. Welcome back to another issue of Spannr. Next Thursday, we'll be taking a little time off to enjoy the holidays. This means the next time you hear from us won't be until...
2023
🎊
Thank you to all our readers who have joined us on this journey. Your support doesn't go unnoticed.
Happy Holidays!
In this week's newsletter
:
✅ Longevity's 2022 highlights & milestones
💸 Business + Funding announcements
📚 Longevity-related good reads from around the web
Annnnd… That’s A Wrap!
The past year has been pretty epic for us folks interested in defying aging. Aside from Spannr officially launching (we know, big deal), there’s been many developments in the space that we can all hang our hats on.For context on longevity’s revolutionary year, in our latest post, we explore all that went down...
Fountain Life, a preventative health and longevity company committed to transforming global healthcare from reactive to proactive, announces $15 million Investment from Eos Venture Partners and Newcross Healthcare
BillionToOne, a molecular diagnostics company with a mission to create powerful and accurate tests that are accessible to all, announces $48.5 million additional capital raise and $35 million upsized term loan facility
Enveda Biosciences, a biotechnology company building the first high-resolution chemical map of the natural world to tackle the toughest problems in drug discovery, closes $68 million combined Series B equity and debt financing
Aktivolabs, a company building digital health solutions to improve the health of people across cultures and countries, closes $10 million Series A from Mitsui to fuel global expansion
Kineta completes reverse merger with Yumanity Therapeutics
Entrada Therapeutics announces clinical hold on IND application for ENTR-601-44 in Duchenne Muscular Dystrophy
Aspen Neuroscience inks $40 Million debt deal with Silicon Valley Bank
LIfT BioSciences investors increase investment in LIfT and Johnson and Johnson welcomes LIfT into JLABS
Vigil Neuroscience appoints David Gray, PH.D., as CSO and announces changes to executive team
MAIA Biotechnology expands phase 2 THIO-101 trial to Europe and holds successful Pre-IND meeting with FDA for planned US expansion
How to Start a Biotech Company in the Longevity Industry (FightAging)
Spinout Playbook: A Guide to Spinning Out of Academia (Fifty Years)
It’s Time to Focus on Reproductive Longevity Research (Wired)
Extreme Biology: Expanding our exploration of the tree of life (The Century of Biology)
Senolytic Therapies Pose Revolutionary Potential to Roll Back Diseases of Aging (BioSpace)
NIH SenNet Consortium to map senescent cells throughout the human lifespan to understand physiological health (Nature Aging)
Melinda French Gates’s tech company bets on $390 billion elder care market (CNBC)
Dr. Rhonda Patrick on Buck Institute Podcast: Training to Age Better (Buck Institute)
Scientists Created Male and Female Cells from a Single Person (Scientific American)
Performance:
Latest Price: $112.437d-Return: -4.53% Market Cap: $9.58b